The use of vancomycin with its therapeutic and adverse effects: a review.

Felipe Ribeiro Bruniera, Felipe Ferreira, L R M Saviolli, Marcelo Rodrigues Bacci, David Feder, Mavilde da Luz Gonçalves Pedreira, Maria Angélica Sorgini Peterlini, Lígia Ajaime Azzalis, Virgínia Junqueira, Fernando Luiz Affonso Fonseca

PubMed · 2015 · 277 citations · 17 references

Full text

Open access

Concepts

TL;DR

Vancomycin, a tricyclic glycopeptide antibiotic from *Streptococcus orientalis*, is widely used to treat severe Gram‑positive infections such as MRSA and penicillin‑resistant pneumococci, including in patients allergic to penicillins or cephalosporins, but its dosing, dilution, and infusion practices are controversial and can lead to toxicity. This review aims to summarize vancomycin’s therapeutic benefits and adverse effects based on recent literature. The authors conducted a systematic literature review of MEDLINE and SciELO articles in English, Portuguese, and Spanish. The review identified major adverse effects—including hypotension, phlebitis, nephrotoxicity, ototoxicity, hypersensitivity reactions, red‑man syndrome, neutropenia, chills, fever, and interstitial nephritis—and highlighted that inadequate dosing and prolonged therapy increase MICs, risking subtherapeutic levels, treatment failures, and toxicity.

Abstract

Vancomycin (VCM) is a tricyclic glycopeptide antibiotic produced by Streptococcus orientalis. Widely used in hospitals, it is indicated to fight severe infections caused by Gram-positive bacteria, especially with the advent of MRSA (methicillin-resistant Staphylococcus aureus), penicillin-resistant pneumococci among others. Furthermore, it is indicated for the treatment of patients allergic to penicillins and cephalosporins. Dose recommendations, dilution rates and types of infusion are controversial and also result in toxic effects. Aim of this paper was to perform a literature review showing the therapeutic and adverse effects of vancomycin.This is a literature review of recent articles published on MEDLINE and SciELO databases in English, Portuguese and Spanish.The main adverse effects of vancomycin are: hypotension, phlebitis, nephrotoxicity, ototoxicity, hypersensitivity reactions, red man syndrome, neutropenia, chills, fever, interstitial nephritis.The use of vancomycin is still very common; however, inadequate doses and prolonged therapy pose a risk of increasing minimum inhibitory concentrations (MICs), resulting in subtherapeutic levels, treatment failures and toxicity. Therefore, further studies should be conducted to optimize the administration of vancomycin, monitoring treatments from the beginning in order to ensure a safe and effective use of the drug.

References

17